Skip to content

Understanding Your Laboratory Test: A Complete Patient Guide

Published: August 9, 2026Updated: August 16, 2026

This test uses FISH technology to detect specific genetic rearrangements in blood or tissue samples that may be associated with certain blood cancers.

Quick summary

{"Detects gene rearrangements in ABL1, ABL2, and PDGFRB genes","Helps diagnose and monitor certain leukemias and myeloproliferative neoplasms","Performed on a blood or tissue sample using fluorescence microscopy","Results help guide treatment decisions with targeted therapies","Abnormal results may indicate conditions like CML or other myeloproliferative disorders"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
96494-0
Short code
ABL1/ABL2/PDGFRB FISH
Synonyms
ABL1 + ABL2 + PDGFRB rearr Bld/T FISH
Category
chemistry
Sample
whole-blood
Container
EDTA (purple top) tube for peripheral blood; tissue specimens should be submitted in sterile transport medium
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
≥ 0 years
Method
Fluorescence In Situ Hybridization (FISH)
CPT
88274,88275
SNOMED
36773004,129133008,129133008
Specimen volume
5-10 mL peripheral blood; tissue minimum 0.5 cm³
Stability
Blood: Process within 24-48 hours of collection, store at 2-8°C. Tissue: Process immediately, store at 2-8°C in transport medium.
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
72–168 hours
Order
routine

This test is a laboratory analysis that helps your healthcare provider learn more about your health. It measures substances in a sample, such as blood or urine, to check how well your body is working and to look for possible signs of illness or disease.

The ABL1, ABL2, and PDGFRB Gene Rearrangement Test is a specialized diagnostic test that uses Fluorescence In Situ Hybridization (FISH) technology. This test looks for specific changes or rearrangements in three genes: ABL1, ABL2, and PDGFRB. These gene rearrangements can be important markers for certain blood cancers and disorders. The test is performed on a sample of whole blood or tissue, where fluorescent probes bind to specific parts of the genes, allowing scientists to see rearrangements under a special microscope.

Your doctor may order this test to help diagnose a medical condition, monitor an ongoing health problem, see how well a treatment is working, or screen for disease early, before you notice any symptoms.

This test is primarily used to help diagnose and monitor conditions such as chronic myeloid leukemia (CML), Philadelphia chromosome-positive leukemias, and other myeloproliferative neoplasms. It may also be used to guide treatment decisions, particularly for targeted therapies like tyrosine kinase inhibitors (TKIs). Additionally, the test can help distinguish between different types of blood disorders and assess how well treatment is working.

The test is done by collecting a small sample, most often blood drawn from a vein in your arm or a urine specimen. The sample is then sent to a laboratory, where trained technicians analyze it and report the findings back to your doctor.

A healthcare provider will collect a blood sample from a vein in your arm, or in some cases, a tissue sample may be obtained through a biopsy. The sample is then sent to a laboratory where specially trained technicians use FISH technology to examine the genes. The process involves adding fluorescent probes to the sample that attach to specific parts of the ABL1, ABL2, and PDGFRB genes. If rearrangements are present, the fluorescent patterns will appear different from normal, which can be detected and analyzed under a fluorescence microscope.

Your results show whether the measured values fall within the normal range for this test. Normal results usually suggest no sign of the condition being checked, while abnormal values may point to a health issue that needs closer evaluation. Always review your results with your doctor, who can explain what they mean for your specific situation.

Normal results mean no specific gene rearrangements were detected in the genes tested. Abnormal results indicate that rearrangements were found in one or more of the genes (ABL1, ABL2, or PDGFRB). These findings can help confirm a diagnosis of certain leukemias or myeloproliferative disorders. Your doctor will interpret these results in conjunction with other clinical findings, other test results, and your overall health condition to determine the best course of action.

Reference range

Negative for ABL1, ABL2, and PDGFRB gene rearrangements. No abnormal fusion signals detected.N/A

Specimen: whole-blood

No special preparation required. Standard venipuncture procedure. Inform the laboratory if patient has received chemotherapy within the past 2-4 weeks as this may affect specimen quality.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Frequently asked questions

Do I need to prepare for this test?
No special preparation is typically required for this test. However, you should inform your doctor about any medications you are taking, as some drugs may affect test results. For blood tests, you may be asked to fast for a short period if other tests are being done simultaneously.
Is the test painful?
The blood draw may cause brief discomfort, similar to a minor pinch. The procedure is generally well-tolerated and takes only a few minutes. If a tissue biopsy is needed, your doctor will discuss any associated discomfort and provide appropriate pain management.
How long does it take to get results?
FISH testing is a specialized procedure that requires specific expertise and equipment. Results typically become available within 5-10 business days, though this may vary depending on the laboratory. Your healthcare provider will contact you with the results or discuss them at your follow-up appointment.
What happens if my results are abnormal?
An abnormal result indicates the presence of gene rearrangements, which your doctor will interpret in the context of your specific condition. This finding often helps confirm a diagnosis and guide treatment decisions. Your hematologist or oncologist will discuss the implications and recommend appropriate next steps, which may include additional testing or specific therapies.
Will my insurance cover this test?
Coverage varies by insurance plan. This test is typically medically necessary for diagnosing and managing specific conditions. We recommend contacting your insurance provider to confirm coverage before the test. Our billing department can also assist with any questions about costs.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy